Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.155
+0.015 (1.32%)
Jun 20, 2025, 11:37 AM - Market open
Pyxis Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 12.76 | 19.47 | 9.66 | 179.29 | 274.74 | 8.08 | Upgrade
|
| Short-Term Investments | 92.67 | 107.46 | 109.63 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 105.43 | 126.93 | 119.3 | 179.29 | 274.74 | 8.08 | Upgrade
|
| Cash Growth | -32.86% | 6.40% | -33.46% | -34.74% | 3300.19% | -58.96% | Upgrade
|
| Other Receivables | - | - | - | 0.6 | - | - | Upgrade
|
| Receivables | - | - | - | 0.6 | - | - | Upgrade
|
| Prepaid Expenses | 4.97 | 0.76 | 1.01 | 1.31 | 1.76 | 0.01 | Upgrade
|
| Restricted Cash | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | - | Upgrade
|
| Other Current Assets | - | 3.28 | 2.82 | 3.94 | 0.7 | 0.02 | Upgrade
|
| Total Current Assets | 111.87 | 132.44 | 124.6 | 186.61 | 278.67 | 8.1 | Upgrade
|
| Property, Plant & Equipment | 21.45 | 22.14 | 24.81 | 24.77 | 1.24 | 1.94 | Upgrade
|
| Other Intangible Assets | 2.54 | 2.6 | 24.31 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.11 | 0.11 | Upgrade
|
| Total Assets | 135.87 | 157.18 | 173.73 | 211.38 | 280.02 | 10.15 | Upgrade
|
| Accounts Payable | 2.85 | 4.86 | 3.9 | 7.1 | 11.95 | 1.08 | Upgrade
|
| Accrued Expenses | 10.08 | 10.73 | 12.62 | 23.45 | 6.33 | 1.88 | Upgrade
|
| Current Portion of Leases | 1.51 | 1.45 | 1.23 | - | 0.17 | 0.62 | Upgrade
|
| Current Unearned Revenue | - | - | 7.66 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 0.64 | 0.36 | 1.09 | 0.27 | 0.12 | Upgrade
|
| Total Current Liabilities | 14.43 | 17.68 | 25.76 | 31.63 | 18.71 | 3.69 | Upgrade
|
| Long-Term Leases | 18.33 | 18.75 | 20.1 | 18.92 | - | 0.17 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 2.16 | - | - | - | Upgrade
|
| Total Liabilities | 32.76 | 36.43 | 48.02 | 50.56 | 18.71 | 3.85 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.03 | 0.03 | 0 | Upgrade
|
| Additional Paid-In Capital | 487.71 | 484.08 | 411.82 | 373.23 | 353 | 0.1 | Upgrade
|
| Retained Earnings | -384.71 | -363.56 | -286.23 | -212.44 | -91.72 | -15.74 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 0.17 | 0.06 | - | - | - | Upgrade
|
| Total Common Equity | 103.1 | 120.75 | 125.7 | 160.82 | 261.31 | -15.65 | Upgrade
|
| Shareholders' Equity | 103.1 | 120.75 | 125.7 | 160.82 | 261.31 | 6.3 | Upgrade
|
| Total Liabilities & Equity | 135.87 | 157.18 | 173.73 | 211.38 | 280.02 | 10.15 | Upgrade
|
| Total Debt | 19.84 | 20.2 | 21.33 | 18.92 | 0.17 | 0.78 | Upgrade
|
| Net Cash (Debt) | 85.59 | 106.73 | 97.97 | 160.37 | 274.57 | 7.3 | Upgrade
|
| Net Cash Growth | -37.18% | 8.95% | -38.91% | -41.59% | 3661.23% | -62.90% | Upgrade
|
| Net Cash Per Share | 1.41 | 1.83 | 2.46 | 4.85 | 32.33 | 7.08 | Upgrade
|
| Filing Date Shares Outstanding | 61.95 | 61.59 | 58.13 | 36.83 | 32.22 | 1.29 | Upgrade
|
| Total Common Shares Outstanding | 61.63 | 59.97 | 44.75 | 34.96 | 32.17 | 1.29 | Upgrade
|
| Working Capital | 97.44 | 114.76 | 98.85 | 154.98 | 259.97 | 4.41 | Upgrade
|
| Book Value Per Share | 1.67 | 2.01 | 2.81 | 4.60 | 8.12 | -12.13 | Upgrade
|
| Tangible Book Value | 100.56 | 118.15 | 101.4 | 160.82 | 261.31 | -15.65 | Upgrade
|
| Tangible Book Value Per Share | 1.63 | 1.97 | 2.27 | 4.60 | 8.12 | -12.13 | Upgrade
|
| Machinery | - | 4.19 | 4.52 | 3.28 | 1.9 | 1.36 | Upgrade
|
| Construction In Progress | - | - | - | 9.18 | - | - | Upgrade
|
| Leasehold Improvements | - | 10.74 | 10.96 | 0.53 | 0.23 | 0.21 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.